Netabolics is a techbio company developing a biosimulation platform for drug discovery and repurposing.
Our patented virtual cell technology integrates multi-omics data, ODE-based modeling, and AI-guided simulation, to causally predict the system-wide effects of genetic and pharmacological interventions on cellular biology.